Clinical trial

The Standard Care Versus Celecoxib Outcome Trial

NCT00447759 · University of Dundee, Other · Completed

Key facts

NCT number NCT00447759
Title The Standard Care Versus Celecoxib Outcome Trial
Official title Phase 4 Study A Large Streamline Safety Study Designed to Compare the Cardiovascular Safety od Celecoxib Versus Traditional Non-selective NSAID's
Acronym SCOTLSSS
Lead sponsor University of Dundee, Other
Collaborators University of Glasgow University of Nottingham
Status Completed
Phase Phase 4
Study type Interventional
Conditions Osteoarthritis, Rheumatoid Arthritis
Intervention type Drug
Interventions Celecoxib, Diclofenac
Enrollment 7,297
Start date Jun 1, 2007
Primary completion Aug 1, 2015
Completion Aug 1, 2015
First posted Mar 15, 2007
Last update posted May 3, 2019
Countries Denmark, Netherlands, United Kingdom

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies